Effect of Dynamic Neuromuscular Stabilization Exercises Versus Conservative Treatment on Pain, Endurance and Flexibility in Non-specific Low Backache

May 8, 2026 updated by: Rida Zainab, University of Health Sciences Lahore

Effect of Dynamic Neuromuscular Stabilization Exercises Versus Conservative Treatment on Pain, Endurance and Flexibility in Allied Health Sciences Students With Non-specific Low Backache

This study is designed to evaluate the effect of Dynamic Neuromuscular Stabilization (DNS) exercises combined with core strengthening exercises in young adults. Dynamic exercsises train motor control and restore natural movement patterns. Participants in experimental group will perform DNS exercise with core strengthening exercises while participants in control group will perform core strengthening exercises alone.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study is aimed to evaluate the effect of Dynamic Neuromuscular Stabilization (DNS) exercises combined with core strengthening exercises in young adults aged 18-25. The prevalence of non-specific low back pain has increased among undergraduate students due to prolonged daily sitting, which leads to decreased flexibility and core muscle endurance. Factors such as individual psychological, anatomical, biomechanical structure, weak strength and endurance of trunk, and decreased flexibility in trunk musculature contribute to non-specific low backache Based on infantile motor patterns, DNS exercises emphasize natural movement patterns to enhance core stability, improve postural control, and reduce pain during both dynamic and static tasks. In this program, participants will learn how to activate deep core muscles and maintain intra-abdominal pressure to train natural movement patterns and improve function. Participants will perform these exercises three times a week for a duration of four weeks.

Various studies in literature including randomized controlled trials reported that DNS along other conventional physiotherapy exercises can reduce pain, disability, quality of life, flexibility of hamstring, balance, abdominal muscle strength in patients with non-specific low backache.

Therefore this study is aimed to see effect of dynamic neuromuscular stabilizaion exercises compared to conservative traetment on pain, endurance and flexibility, which are contributing factors to non-specific low back pain (NSLBP).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
56

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Pakistan
      • Lahore, Pakistan
        • Rida Zainab
    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 39350
        • University of Health Sciences Lahore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Allied Health Sciences students aged 18-25 years
  • Participants having non-specific low backache
  • Visual Analogue scale (VAS) equal to or greater than 3
  • Body Mass Index (BMI) < 28kg/m2

Exclusion Criteria:

  • Previous back surgery, tumors, deformities, infection
  • Low backache associated with trauma
  • Low backache with neurological symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention Group
Other: Core Strengthening Exercises
Participants in control group will perform only conventional core strengthening exercises. These exercises increase strength of core muscles which in returns leads to increased spinal stability and postural control.
Other: Dynamic Neuromuscular Stabilization Exercises
Participants will perform following 6 dynamic neuromuscular stabilization exercises based on developmental kinesiology and emphasize neuromuscular control. Which will provide stability, postural control, motor control, restore natural movement patterns and correct spinal alignment during static and dynamic tasks.
Active Comparator: Control Group
Other: Core Strengthening Exercises
Participants in control group will perform only conventional core strengthening exercises. These exercises increase strength of core muscles which in returns leads to increased spinal stability and postural control.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS)
Time Frame: From enrollment to the end of treatment at 4 weeks.
Pain intensity is measured via Visual Analogue Scale (VAS), a 10cm(100mm) long line where''0" indicate no pain and "10" indicate worst pain. It is a self-reported scale. Patient will be explained by these two extremes and asked to mark point on the scale that best describe his/her level of pain intensity.
From enrollment to the end of treatment at 4 weeks.
McGill's Core Endurance Test
Time Frame: From enrollment to the end of treatment at 4 weeks.
Endurance of core musculature is evaluated by using McGill's core endurance battery tests i.e. flexors, extensors, lateral core muscle tests. Participants will be guided to hold positions according to the testing muscles. Duration of hold will be recorded in seconds via stopwatch in their respective positions until participants are unable to hold positions of test.
From enrollment to the end of treatment at 4 weeks.
Sit-and-reach Test
Time Frame: From enrollment to the end of treatment at 4 weeks.
participant will sit on floor with shoes off. Yard stick is placed between feet and tape is placed at 15 inches mark right angle to yard stick. Heels of feet should be at the level of yard stick with 10-12 inches apart. Participant will reach forward with arms extended and one hand placed on other hand with palms facing downward, as forward as possible, maintaining this position for 2 seconds. For best attempt participant during reach participant will exhale and drop head between extended arms. Knee should be extended throughout test and breathing should be normal, avoid breath holding at any time during test. Distance will be measured as most distant point reached in centimeters or inches.
From enrollment to the end of treatment at 4 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Health Sciences Lahore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 23, 2026

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 23, 2026

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
April 4, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 22, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 22, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 27, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 13, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 8, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • UHS/USERC-26/SEC/86

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-specific Low Back Pain (NSLBP)

Clinical Trials on Core Strengthening Exercises

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings